Literature DB >> 10931049

Influence of a specialized leg ulcer service on management and outcome.

A S Ghauri1, M C Taylor, J E Deacon, M R Whyman, J J Earnshaw, B P Heather, K R Poskitt.   

Abstract

BACKGROUND: The organization of leg ulcer care is poorly defined in the community. This study assessed the overall influence of a specialized community service on management and outcome of chronic leg ulcers, irrespective of aetiology.
METHODS: Assessment and outcome of ulcers were compared in patient samples (n = 200) from East and West Gloucestershire, before and after the introduction of specialized clinics into East Gloucestershire. In clinics, vascular disease was routinely assessed by duplex scanning and determination of the ankle : brachial pressure index.
RESULTS: There was no coordinated community structure for the care of patients with leg ulcers before the service was introduced, and 74 and 67 per cent of limbs in East and West Gloucestershire respectively had aetiology undiagnosed. After introduction of the clinics, the 12-week healing rate increased from 12 to 22 per cent in East Gloucestershire (P = 0. 05) and to 47 per cent in the specialized East Gloucestershire clinics (P < 0.001). The 12-month recurrence rate decreased from 50 to 41 per cent in East Gloucestershire and to 17 per cent in the East clinics (P < 0.001). The West Gloucestershire control showed no significant changes.
CONCLUSION: A specialized leg ulcer service with defined protocols provides an improved management structure for treating patients with leg ulcers in the community. Accurate diagnosis of chronic leg ulcers and improved outcome may be achieved within this specialized service.

Entities:  

Mesh:

Year:  2000        PMID: 10931049     DOI: 10.1046/j.1365-2168.2000.01491.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  Improved wound management at lower cost: a sensible goal for Australia.

Authors:  Rosana E Norman; Michelle Gibb; Anthony Dyer; Jennifer Prentice; Stephen Yelland; Qinglu Cheng; Peter A Lazzarini; Keryln Carville; Karen Innes-Walker; Kathleen Finlayson; Helen Edwards; Edward Burn; Nicholas Graves
Journal:  Int Wound J       Date:  2015-12-03       Impact factor: 3.315

Review 2.  Assessing and comparing the quality of wound centres: a literature review and benchmarking pilot.

Authors:  Lotte Pruim; Anke Wind; Wim H van Harten
Journal:  Int Wound J       Date:  2017-06-13       Impact factor: 3.315

3.  Predicting the likelihood of venous leg ulcer recurrence: The diagnostic accuracy of a newly developed risk assessment tool.

Authors:  Kathleen J Finlayson; Christina N Parker; Charne Miller; Michelle Gibb; Suzanne Kapp; Rajna Ogrin; Jacinta Anderson; Kerrie Coleman; Dianne Smith; Helen E Edwards
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

4.  Randomised controlled trial comparing European standard class 1 to class 2 compression stockings for ulcer recurrence and patient compliance.

Authors:  Mary Clarke-Moloney; Niamh Keane; Veronica O'Connor; Mary Anna Ryan; Helen Meagher; Pierce A Grace; Eamon Kavanagh; Stewart R Walsh; Paul E Burke
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

5.  Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial.

Authors:  Manjit S Gohel; Jamie R Barwell; Maxine Taylor; Terry Chant; Chris Foy; Jonothan J Earnshaw; Brian P Heather; David C Mitchell; Mark R Whyman; Keith R Poskitt
Journal:  BMJ       Date:  2007-06-01

6.  Ultrasound-guided foam sclerotherapy for chronic venous disease with ulcer. A prospective multiple outcome cohort study.

Authors:  Guilherme Camargo Gonçalves de Abreu; Otacílio de Camargo; Márcia Fayad Marcondes de Abreu; José Luis Braga de Aquino
Journal:  J Vasc Bras       Date:  2020-03-10

7.  Health service pathways for patients with chronic leg ulcers: identifying effective pathways for facilitation of evidence based wound care.

Authors:  Helen Edwards; Kathleen Finlayson; Mary Courtney; Nick Graves; Michelle Gibb; Christina Parker
Journal:  BMC Health Serv Res       Date:  2013-03-08       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.